Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Carcinoma, Non-Small-Cell Lung | 99 | 2024 | 5230 | 11.010 |
Why?
|
Lung Neoplasms | 119 | 2024 | 13112 | 8.340 |
Why?
|
Proto-Oncogene Proteins c-met | 12 | 2023 | 579 | 2.930 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 15 | 2023 | 1691 | 1.710 |
Why?
|
Protein Kinase Inhibitors | 21 | 2023 | 5532 | 1.560 |
Why?
|
Mutation | 55 | 2023 | 29777 | 1.560 |
Why?
|
Small Cell Lung Carcinoma | 6 | 2022 | 388 | 1.430 |
Why?
|
Immunotherapy | 21 | 2023 | 4437 | 1.420 |
Why?
|
Exons | 8 | 2020 | 2438 | 1.370 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 26 | 2024 | 11524 | 1.210 |
Why?
|
Antineoplastic Agents | 19 | 2024 | 13691 | 1.150 |
Why?
|
Drug Resistance, Neoplasm | 15 | 2021 | 5170 | 1.090 |
Why?
|
Pyrazoles | 9 | 2019 | 1970 | 0.970 |
Why?
|
Pyridines | 10 | 2021 | 2827 | 0.950 |
Why?
|
Proto-Oncogene Proteins | 8 | 2023 | 4552 | 0.870 |
Why?
|
Platinum | 5 | 2024 | 231 | 0.840 |
Why?
|
Oximes | 3 | 2020 | 311 | 0.830 |
Why?
|
Thoracic Neoplasms | 2 | 2021 | 268 | 0.800 |
Why?
|
Acetonitriles | 1 | 2021 | 53 | 0.790 |
Why?
|
Cancer Vaccines | 3 | 2023 | 1023 | 0.740 |
Why?
|
Proto-Oncogene Proteins B-raf | 3 | 2019 | 2039 | 0.720 |
Why?
|
NF-E2-Related Factor 2 | 7 | 2024 | 379 | 0.710 |
Why?
|
Protein-Tyrosine Kinases | 7 | 2023 | 2453 | 0.700 |
Why?
|
Humans | 160 | 2024 | 743811 | 0.660 |
Why?
|
Pyrimidinones | 2 | 2018 | 370 | 0.640 |
Why?
|
Biliary Tract Diseases | 1 | 2019 | 161 | 0.630 |
Why?
|
Receptor Protein-Tyrosine Kinases | 10 | 2023 | 1660 | 0.620 |
Why?
|
Translocation, Genetic | 2 | 2013 | 1420 | 0.610 |
Why?
|
Drug Resistance | 2 | 2013 | 1606 | 0.590 |
Why?
|
High-Throughput Nucleotide Sequencing | 8 | 2021 | 3591 | 0.580 |
Why?
|
Pteridines | 1 | 2016 | 45 | 0.580 |
Why?
|
Aged, 80 and over | 34 | 2022 | 57744 | 0.570 |
Why?
|
Pyrimidines | 5 | 2024 | 2945 | 0.560 |
Why?
|
Retrospective Studies | 39 | 2024 | 77410 | 0.560 |
Why?
|
Pyridones | 2 | 2018 | 711 | 0.540 |
Why?
|
Arrhythmogenic Right Ventricular Dysplasia | 2 | 2008 | 161 | 0.530 |
Why?
|
Neoplasms | 16 | 2023 | 21675 | 0.530 |
Why?
|
Aged | 61 | 2023 | 163178 | 0.520 |
Why?
|
Prednisone | 1 | 2019 | 1574 | 0.490 |
Why?
|
Hepatitis B | 1 | 2020 | 693 | 0.480 |
Why?
|
Imidazoles | 2 | 2018 | 1206 | 0.480 |
Why?
|
Diabetic Ketoacidosis | 1 | 2017 | 247 | 0.470 |
Why?
|
HIV | 2 | 2018 | 1604 | 0.470 |
Why?
|
Lymphocytes | 1 | 2021 | 2615 | 0.460 |
Why?
|
Mesothelioma | 2 | 2016 | 818 | 0.460 |
Why?
|
Antibodies, Monoclonal | 8 | 2024 | 9272 | 0.450 |
Why?
|
Tumor Burden | 6 | 2023 | 1917 | 0.450 |
Why?
|
Middle Aged | 57 | 2022 | 213241 | 0.440 |
Why?
|
Neutrophils | 3 | 2021 | 3718 | 0.440 |
Why?
|
Female | 72 | 2023 | 380020 | 0.410 |
Why?
|
Male | 68 | 2023 | 349776 | 0.410 |
Why?
|
Adenocarcinoma | 6 | 2018 | 6363 | 0.400 |
Why?
|
Adrenal Cortex Hormones | 3 | 2019 | 1854 | 0.400 |
Why?
|
Pleural Neoplasms | 1 | 2016 | 608 | 0.400 |
Why?
|
Pneumonia | 3 | 2023 | 2133 | 0.400 |
Why?
|
Brain Neoplasms | 6 | 2023 | 8856 | 0.380 |
Why?
|
Piperazines | 1 | 2021 | 2487 | 0.380 |
Why?
|
Gastrointestinal Diseases | 1 | 2019 | 1171 | 0.370 |
Why?
|
Plakophilins | 2 | 2008 | 34 | 0.370 |
Why?
|
Desmoglein 2 | 2 | 2008 | 12 | 0.370 |
Why?
|
Ligands | 3 | 2023 | 3281 | 0.370 |
Why?
|
Liver Neoplasms | 3 | 2023 | 4251 | 0.360 |
Why?
|
Genomics | 9 | 2024 | 5714 | 0.360 |
Why?
|
Neoplasm Staging | 10 | 2021 | 11036 | 0.350 |
Why?
|
DNA Helicases | 4 | 2023 | 861 | 0.350 |
Why?
|
Hepatitis C | 1 | 2020 | 1591 | 0.350 |
Why?
|
Autoimmune Diseases | 2 | 2019 | 2134 | 0.350 |
Why?
|
Carboplatin | 4 | 2020 | 801 | 0.340 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2016 | 1821 | 0.340 |
Why?
|
Prognosis | 10 | 2022 | 29052 | 0.340 |
Why?
|
Heart Transplantation | 3 | 2017 | 3113 | 0.330 |
Why?
|
T-Lymphocytes | 3 | 2021 | 10179 | 0.310 |
Why?
|
Tumor Microenvironment | 7 | 2024 | 3583 | 0.310 |
Why?
|
Adult | 37 | 2023 | 213889 | 0.310 |
Why?
|
Molecular Targeted Therapy | 5 | 2020 | 2727 | 0.290 |
Why?
|
Cell Cycle Proteins | 3 | 2020 | 3463 | 0.280 |
Why?
|
Treatment Outcome | 21 | 2021 | 63042 | 0.270 |
Why?
|
Drug Hypersensitivity | 1 | 2014 | 884 | 0.270 |
Why?
|
Immunophenotyping | 2 | 2024 | 1880 | 0.270 |
Why?
|
RNA Splice Sites | 1 | 2006 | 209 | 0.260 |
Why?
|
Proto-Oncogene Proteins c-ret | 4 | 2023 | 220 | 0.260 |
Why?
|
Survival Rate | 7 | 2021 | 12786 | 0.250 |
Why?
|
Disease-Free Survival | 4 | 2020 | 6895 | 0.240 |
Why?
|
Palliative Care | 1 | 2019 | 3490 | 0.240 |
Why?
|
Tomography, X-Ray Computed | 8 | 2020 | 20121 | 0.230 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2019 | 4033 | 0.230 |
Why?
|
Carcinoma, Renal Cell | 2 | 2015 | 3142 | 0.220 |
Why?
|
HIV Infections | 2 | 2021 | 16715 | 0.220 |
Why?
|
Cardiomegaly | 1 | 2006 | 621 | 0.220 |
Why?
|
Aneuploidy | 2 | 2023 | 530 | 0.220 |
Why?
|
Gene Amplification | 2 | 2018 | 1063 | 0.220 |
Why?
|
Apoptosis | 5 | 2023 | 9718 | 0.210 |
Why?
|
Colorectal Neoplasms | 2 | 2021 | 6773 | 0.210 |
Why?
|
Sulfonamides | 2 | 2024 | 1938 | 0.210 |
Why?
|
Platinum Compounds | 1 | 2022 | 96 | 0.200 |
Why?
|
Kidney Transplantation | 1 | 2017 | 4251 | 0.200 |
Why?
|
Kidney Neoplasms | 2 | 2015 | 4260 | 0.200 |
Why?
|
Melanoma | 3 | 2020 | 5508 | 0.190 |
Why?
|
Gene Expression Regulation, Neoplastic | 6 | 2020 | 8430 | 0.190 |
Why?
|
Sucrose | 1 | 2021 | 164 | 0.190 |
Why?
|
Gene Rearrangement | 5 | 2021 | 1179 | 0.190 |
Why?
|
Morpholines | 1 | 2024 | 571 | 0.190 |
Why?
|
Nuclear Proteins | 4 | 2023 | 5854 | 0.180 |
Why?
|
Kaplan-Meier Estimate | 4 | 2020 | 6539 | 0.180 |
Why?
|
Smoking | 4 | 2022 | 8984 | 0.180 |
Why?
|
Chromosomes | 1 | 2023 | 596 | 0.180 |
Why?
|
Indazoles | 1 | 2021 | 290 | 0.180 |
Why?
|
Protein Conformation | 2 | 2021 | 4009 | 0.180 |
Why?
|
Phospholipase D | 1 | 2019 | 70 | 0.170 |
Why?
|
Transcription Factors | 5 | 2023 | 12209 | 0.170 |
Why?
|
Appendiceal Neoplasms | 1 | 2021 | 146 | 0.170 |
Why?
|
Survival Analysis | 4 | 2020 | 10251 | 0.170 |
Why?
|
Disease Progression | 4 | 2021 | 13273 | 0.170 |
Why?
|
Colitis, Microscopic | 1 | 2020 | 77 | 0.170 |
Why?
|
Lymphoma, Mantle-Cell | 1 | 2021 | 233 | 0.160 |
Why?
|
Etoposide | 1 | 2020 | 641 | 0.160 |
Why?
|
Radiation Pneumonitis | 1 | 2019 | 104 | 0.160 |
Why?
|
Receptors, Fibroblast Growth Factor | 1 | 2019 | 185 | 0.160 |
Why?
|
CD8-Positive T-Lymphocytes | 5 | 2024 | 4477 | 0.160 |
Why?
|
Sarcoidosis, Pulmonary | 1 | 2018 | 43 | 0.160 |
Why?
|
Benzeneacetamides | 1 | 2017 | 39 | 0.150 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2021 | 604 | 0.150 |
Why?
|
Patient Selection | 3 | 2019 | 4210 | 0.150 |
Why?
|
Antigens, Neoplasm | 2 | 2022 | 1988 | 0.150 |
Why?
|
Quinoxalines | 1 | 2019 | 289 | 0.150 |
Why?
|
BRCA2 Protein | 1 | 2022 | 794 | 0.150 |
Why?
|
Chromosome Aberrations | 1 | 2023 | 1811 | 0.140 |
Why?
|
Glutamate Decarboxylase | 1 | 2017 | 246 | 0.140 |
Why?
|
Arrhythmias, Cardiac | 1 | 2006 | 2267 | 0.140 |
Why?
|
Microsatellite Repeats | 1 | 2018 | 799 | 0.140 |
Why?
|
Early Diagnosis | 1 | 2021 | 1186 | 0.130 |
Why?
|
Granuloma | 1 | 2018 | 319 | 0.130 |
Why?
|
Radiography, Abdominal | 1 | 2019 | 537 | 0.130 |
Why?
|
Vaccination | 3 | 2023 | 3275 | 0.130 |
Why?
|
Tumor Suppressor Protein p53 | 3 | 2024 | 2944 | 0.130 |
Why?
|
BRCA1 Protein | 1 | 2022 | 1148 | 0.130 |
Why?
|
Indoles | 1 | 2024 | 1841 | 0.130 |
Why?
|
Antilymphocyte Serum | 1 | 2017 | 492 | 0.130 |
Why?
|
Inflammatory Bowel Diseases | 2 | 2020 | 2428 | 0.130 |
Why?
|
Incidence | 3 | 2023 | 20948 | 0.130 |
Why?
|
Prednisolone | 1 | 2016 | 334 | 0.130 |
Why?
|
Causality | 1 | 2021 | 1275 | 0.130 |
Why?
|
Sulfones | 2 | 2014 | 434 | 0.120 |
Why?
|
Janus Kinase 2 | 1 | 2018 | 528 | 0.120 |
Why?
|
Solitary Pulmonary Nodule | 1 | 2018 | 266 | 0.120 |
Why?
|
Fluorodeoxyglucose F18 | 2 | 2022 | 2016 | 0.120 |
Why?
|
Hydroxamic Acids | 1 | 2017 | 494 | 0.120 |
Why?
|
Heart Ventricles | 1 | 2006 | 3817 | 0.120 |
Why?
|
Immune System | 1 | 2019 | 807 | 0.110 |
Why?
|
Neutrophil Infiltration | 1 | 2016 | 390 | 0.110 |
Why?
|
Pneumonectomy | 1 | 2020 | 1098 | 0.110 |
Why?
|
Piperidines | 1 | 2021 | 1601 | 0.110 |
Why?
|
Neoadjuvant Therapy | 2 | 2022 | 2727 | 0.110 |
Why?
|
Medical Oncology | 2 | 2022 | 2267 | 0.110 |
Why?
|
Neoplasm Metastasis | 2 | 2022 | 4848 | 0.110 |
Why?
|
In Situ Hybridization, Fluorescence | 4 | 2021 | 2649 | 0.100 |
Why?
|
Clinical Trials as Topic | 2 | 2021 | 7908 | 0.100 |
Why?
|
Young Adult | 8 | 2022 | 56392 | 0.100 |
Why?
|
Genotype | 3 | 2021 | 12944 | 0.100 |
Why?
|
Follow-Up Studies | 5 | 2020 | 39001 | 0.100 |
Why?
|
Colitis | 1 | 2020 | 1170 | 0.100 |
Why?
|
Sequence Homology, Amino Acid | 2 | 2006 | 2839 | 0.100 |
Why?
|
Cohort Studies | 7 | 2023 | 40545 | 0.100 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2017 | 789 | 0.100 |
Why?
|
Remission Induction | 1 | 2017 | 2384 | 0.100 |
Why?
|
HSP90 Heat-Shock Proteins | 1 | 2014 | 434 | 0.100 |
Why?
|
Guanine | 1 | 2012 | 274 | 0.100 |
Why?
|
Glutamates | 1 | 2012 | 397 | 0.100 |
Why?
|
Interleukin-17 | 1 | 2017 | 902 | 0.100 |
Why?
|
Neoplasm Recurrence, Local | 5 | 2023 | 9239 | 0.100 |
Why?
|
Renal Insufficiency | 1 | 2017 | 805 | 0.100 |
Why?
|
Anemia, Hemolytic, Autoimmune | 1 | 2012 | 142 | 0.090 |
Why?
|
Treatment Failure | 1 | 2016 | 2617 | 0.090 |
Why?
|
Anti-Bacterial Agents | 2 | 2021 | 7172 | 0.090 |
Why?
|
Interleukin-6 | 1 | 2020 | 3208 | 0.090 |
Why?
|
Postoperative Care | 1 | 2017 | 1485 | 0.090 |
Why?
|
Immunohistochemistry | 4 | 2018 | 11360 | 0.090 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2021 | 1596 | 0.090 |
Why?
|
Disease Management | 1 | 2021 | 2459 | 0.090 |
Why?
|
Neoplasms, Glandular and Epithelial | 1 | 2013 | 484 | 0.080 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2020 | 2916 | 0.080 |
Why?
|
Radiopharmaceuticals | 1 | 2019 | 2647 | 0.080 |
Why?
|
Feasibility Studies | 1 | 2019 | 5078 | 0.080 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 3 | 2023 | 1038 | 0.080 |
Why?
|
Autoantibodies | 1 | 2017 | 2037 | 0.080 |
Why?
|
Desmocollins | 1 | 2008 | 12 | 0.080 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2013 | 1213 | 0.080 |
Why?
|
gamma Catenin | 1 | 2008 | 44 | 0.080 |
Why?
|
Hematopoiesis | 1 | 2018 | 2073 | 0.080 |
Why?
|
Fatal Outcome | 1 | 2013 | 1851 | 0.080 |
Why?
|
DNA Mutational Analysis | 3 | 2020 | 4183 | 0.080 |
Why?
|
Desmoplakins | 1 | 2008 | 62 | 0.080 |
Why?
|
Time Factors | 5 | 2021 | 40038 | 0.080 |
Why?
|
ras Proteins | 1 | 2013 | 1059 | 0.080 |
Why?
|
Sarcoidosis | 1 | 2013 | 506 | 0.080 |
Why?
|
Sequence Analysis, DNA | 1 | 2019 | 4803 | 0.080 |
Why?
|
Recurrence | 2 | 2016 | 8337 | 0.070 |
Why?
|
Immune Tolerance | 1 | 2016 | 2258 | 0.070 |
Why?
|
Structure-Activity Relationship | 1 | 2013 | 3128 | 0.070 |
Why?
|
Mice | 12 | 2023 | 81154 | 0.070 |
Why?
|
Lymphoma | 1 | 2016 | 1875 | 0.070 |
Why?
|
Immunosuppressive Agents | 2 | 2017 | 4152 | 0.070 |
Why?
|
Arthritis, Rheumatoid | 1 | 2022 | 3712 | 0.070 |
Why?
|
Drug Discovery | 1 | 2014 | 1058 | 0.070 |
Why?
|
Positron-Emission Tomography | 1 | 2022 | 6237 | 0.070 |
Why?
|
MAP Kinase Kinase 1 | 2 | 2020 | 334 | 0.070 |
Why?
|
Flow Cytometry | 1 | 2016 | 5973 | 0.070 |
Why?
|
Xenograft Model Antitumor Assays | 3 | 2018 | 3547 | 0.060 |
Why?
|
Healthcare Disparities | 1 | 2020 | 3155 | 0.060 |
Why?
|
Base Sequence | 2 | 2006 | 12798 | 0.060 |
Why?
|
Predictive Value of Tests | 1 | 2021 | 15067 | 0.060 |
Why?
|
Proportional Hazards Models | 1 | 2019 | 12354 | 0.060 |
Why?
|
Animals | 14 | 2023 | 168660 | 0.060 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2019 | 3047 | 0.060 |
Why?
|
Prospective Studies | 7 | 2022 | 53250 | 0.060 |
Why?
|
Amino Acid Sequence | 2 | 2006 | 13809 | 0.060 |
Why?
|
Ventricular Function, Right | 1 | 2008 | 589 | 0.060 |
Why?
|
Cell Line, Tumor | 5 | 2020 | 16674 | 0.060 |
Why?
|
Genome-Wide Association Study | 1 | 2022 | 12259 | 0.060 |
Why?
|
Lung | 5 | 2020 | 9858 | 0.060 |
Why?
|
Length of Stay | 1 | 2017 | 6311 | 0.060 |
Why?
|
Telemedicine | 1 | 2020 | 2874 | 0.060 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2023 | 9944 | 0.060 |
Why?
|
Molecular Sequence Data | 2 | 2006 | 18107 | 0.060 |
Why?
|
Algorithms | 3 | 2023 | 13869 | 0.060 |
Why?
|
Chromosomal Instability | 1 | 2004 | 183 | 0.060 |
Why?
|
Vaccines, Subunit | 1 | 2023 | 168 | 0.050 |
Why?
|
Quinuclidines | 1 | 2022 | 24 | 0.050 |
Why?
|
Erythrocytes | 1 | 2012 | 2455 | 0.050 |
Why?
|
Insulin | 1 | 2017 | 6584 | 0.050 |
Why?
|
Genetic Testing | 2 | 2022 | 3439 | 0.050 |
Why?
|
Interleukin-7 | 1 | 2022 | 142 | 0.050 |
Why?
|
RNA Splicing | 1 | 2006 | 907 | 0.050 |
Why?
|
Administration, Oral | 2 | 2020 | 3912 | 0.050 |
Why?
|
Oncogenes | 2 | 2021 | 1265 | 0.050 |
Why?
|
Risk Factors | 5 | 2022 | 72252 | 0.050 |
Why?
|
DNA Primers | 1 | 2006 | 2891 | 0.050 |
Why?
|
Cardiomyopathies | 1 | 2013 | 1911 | 0.050 |
Why?
|
Heart Failure | 2 | 2017 | 10896 | 0.050 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2023 | 2938 | 0.050 |
Why?
|
Cytokines | 1 | 2016 | 7324 | 0.050 |
Why?
|
Loss of Heterozygosity | 1 | 2022 | 684 | 0.050 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2022 | 646 | 0.040 |
Why?
|
Age Factors | 1 | 2016 | 18355 | 0.040 |
Why?
|
Pedigree | 1 | 2006 | 4643 | 0.040 |
Why?
|
Germ Cells | 1 | 2022 | 629 | 0.040 |
Why?
|
Aniline Compounds | 1 | 2023 | 986 | 0.040 |
Why?
|
Genetic Markers | 2 | 2016 | 2634 | 0.040 |
Why?
|
Pattern Recognition, Automated | 1 | 2005 | 1001 | 0.040 |
Why?
|
Epigenomics | 1 | 2023 | 903 | 0.040 |
Why?
|
Mice, Transgenic | 2 | 2023 | 9731 | 0.040 |
Why?
|
Enzyme Activation | 2 | 2014 | 3701 | 0.040 |
Why?
|
New York City | 1 | 2020 | 705 | 0.040 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2005 | 1184 | 0.040 |
Why?
|
Combined Modality Therapy | 2 | 2022 | 8637 | 0.040 |
Why?
|
Retreatment | 1 | 2019 | 609 | 0.040 |
Why?
|
Albumins | 1 | 2020 | 568 | 0.040 |
Why?
|
Robotics | 1 | 2005 | 899 | 0.040 |
Why?
|
Protein Isoforms | 1 | 2022 | 1729 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 3 | 2022 | 17439 | 0.040 |
Why?
|
Pandemics | 3 | 2022 | 8385 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2020 | 10940 | 0.040 |
Why?
|
Surgery, Computer-Assisted | 1 | 2005 | 1017 | 0.040 |
Why?
|
Disease Models, Animal | 3 | 2021 | 18027 | 0.030 |
Why?
|
Uncertainty | 1 | 2021 | 735 | 0.030 |
Why?
|
Genetic Heterogeneity | 1 | 2019 | 733 | 0.030 |
Why?
|
Radiotherapy Dosage | 1 | 2022 | 2879 | 0.030 |
Why?
|
Forkhead Transcription Factors | 1 | 2022 | 1613 | 0.030 |
Why?
|
Myocardium | 1 | 2008 | 4775 | 0.030 |
Why?
|
Lipopolysaccharides | 1 | 2022 | 2217 | 0.030 |
Why?
|
Proto-Oncogene Proteins pp60(c-src) | 1 | 2014 | 146 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2022 | 2307 | 0.030 |
Why?
|
Cranial Irradiation | 1 | 2017 | 401 | 0.030 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 3 | 1 | 2014 | 105 | 0.030 |
Why?
|
Germ-Line Mutation | 1 | 2022 | 1787 | 0.030 |
Why?
|
Diagnostic Errors | 1 | 2021 | 1256 | 0.030 |
Why?
|
Echocardiography | 1 | 2006 | 5096 | 0.030 |
Why?
|
Mutation, Missense | 1 | 2023 | 2566 | 0.030 |
Why?
|
Communicable Disease Control | 1 | 2020 | 856 | 0.030 |
Why?
|
Natural Killer T-Cells | 1 | 2017 | 316 | 0.030 |
Why?
|
Anilides | 1 | 2016 | 409 | 0.030 |
Why?
|
Rosette Formation | 1 | 2012 | 153 | 0.030 |
Why?
|
Drug Synergism | 1 | 2017 | 1794 | 0.030 |
Why?
|
Paclitaxel | 1 | 2020 | 1705 | 0.030 |
Why?
|
Thymidylate Synthase | 1 | 2012 | 75 | 0.030 |
Why?
|
Cell Proliferation | 2 | 2020 | 10477 | 0.030 |
Why?
|
DNA, Neoplasm | 1 | 2018 | 1758 | 0.030 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2016 | 610 | 0.030 |
Why?
|
Histone Deacetylases | 1 | 2017 | 727 | 0.030 |
Why?
|
Immunity | 1 | 2018 | 1013 | 0.030 |
Why?
|
Antibody Formation | 1 | 2017 | 1402 | 0.030 |
Why?
|
Epidemiologic Methods | 1 | 2017 | 1364 | 0.030 |
Why?
|
Graft Rejection | 2 | 2017 | 4398 | 0.030 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2014 | 729 | 0.030 |
Why?
|
Prevalence | 2 | 2021 | 15211 | 0.030 |
Why?
|
Gene Deletion | 1 | 2020 | 2749 | 0.030 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2020 | 3480 | 0.020 |
Why?
|
Catheter Ablation | 1 | 2005 | 2758 | 0.020 |
Why?
|
Biopsy, Fine-Needle | 1 | 2016 | 1094 | 0.020 |
Why?
|
Hospitalization | 2 | 2021 | 10259 | 0.020 |
Why?
|
DNA Repair | 1 | 2020 | 2045 | 0.020 |
Why?
|
Cytomegalovirus Infections | 1 | 2017 | 820 | 0.020 |
Why?
|
International Cooperation | 1 | 2017 | 1419 | 0.020 |
Why?
|
Reperfusion Injury | 1 | 2017 | 1027 | 0.020 |
Why?
|
DNA Damage | 1 | 2020 | 2429 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2018 | 4931 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2021 | 14714 | 0.020 |
Why?
|
DNA Copy Number Variations | 1 | 2018 | 1937 | 0.020 |
Why?
|
Cell Survival | 1 | 2020 | 5881 | 0.020 |
Why?
|
Neoplasms, Radiation-Induced | 1 | 2013 | 547 | 0.020 |
Why?
|
Mice, SCID | 1 | 2014 | 2718 | 0.020 |
Why?
|
Pilot Projects | 1 | 2021 | 8316 | 0.020 |
Why?
|
Alleles | 1 | 2019 | 6934 | 0.020 |
Why?
|
Lymphatic Metastasis | 1 | 2015 | 2924 | 0.020 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2020 | 2248 | 0.020 |
Why?
|
Environment | 1 | 2013 | 1121 | 0.020 |
Why?
|
Attitude of Health Personnel | 1 | 2021 | 3839 | 0.020 |
Why?
|
Boston | 1 | 2020 | 9310 | 0.020 |
Why?
|
DNA-Binding Proteins | 2 | 2020 | 9648 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 2014 | 6311 | 0.020 |
Why?
|
Insurance, Health | 1 | 2019 | 2492 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2020 | 12020 | 0.020 |
Why?
|
Signal Transduction | 2 | 2020 | 23398 | 0.020 |
Why?
|
Transcription, Genetic | 1 | 2020 | 7719 | 0.020 |
Why?
|
Cognition | 1 | 2022 | 6759 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2019 | 12243 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2021 | 9440 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2020 | 14563 | 0.020 |
Why?
|
Radiography | 1 | 2015 | 7010 | 0.020 |
Why?
|
Electronic Health Records | 1 | 2021 | 4467 | 0.010 |
Why?
|
Body Mass Index | 1 | 2022 | 12718 | 0.010 |
Why?
|
Gene Expression | 1 | 2017 | 7793 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2022 | 21733 | 0.010 |
Why?
|
Heart Diseases | 1 | 2017 | 2789 | 0.010 |
Why?
|
Genetic Variation | 1 | 2019 | 6535 | 0.010 |
Why?
|
Diagnostic Imaging | 1 | 2018 | 3503 | 0.010 |
Why?
|
B-Lymphocytes | 1 | 2017 | 4665 | 0.010 |
Why?
|
Punctures | 1 | 2005 | 374 | 0.010 |
Why?
|
Graft Survival | 1 | 2013 | 3734 | 0.010 |
Why?
|
Models, Biological | 1 | 2018 | 9582 | 0.010 |
Why?
|
Registries | 1 | 2017 | 8090 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2021 | 25032 | 0.010 |
Why?
|
Cluster Analysis | 1 | 2005 | 2712 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2016 | 15518 | 0.010 |
Why?
|
Drosophila melanogaster | 1 | 2004 | 1712 | 0.010 |
Why?
|
Image Enhancement | 1 | 2005 | 2915 | 0.010 |
Why?
|
Artificial Intelligence | 1 | 2005 | 2210 | 0.010 |
Why?
|
Imaging, Three-Dimensional | 1 | 2005 | 4033 | 0.010 |
Why?
|
United States | 1 | 2016 | 69859 | 0.000 |
Why?
|
Reproducibility of Results | 1 | 2005 | 19894 | 0.000 |
Why?
|